Breast Cancer Risk Assessment: The BI-RADS calculator helps assess the risk of malignancy in breast lesions based on mammography, ultrasound, and MRI findings, assigning a score that ranges from 0 (inconclusive) to 6 (known malignancy), guiding clinical decision-making.

Treatment and Follow-Up Planning: It aids in standardizing breast cancer diagnosis and follow-up protocols, ensuring consistent monitoring and appropriate intervention, whether for biopsy, further imaging, or treatment options.

Thyroid Nodule Evaluation: The TIRADS calculator provides a standardized framework to classify thyroid nodules based on ultrasound characteristics (such as size, shape, and echogenicity), helping to determine the likelihood of malignancy.

Clinical Decision Support: It assists in decision-making regarding the need for biopsy, follow-up imaging, or monitoring, thereby optimizing patient management and minimizing unnecessary procedures.

Ovarian and Adnexal Lesion Assessment: The OI-RADS calculator provides a structured system to categorize ovarian and adnexal lesions on imaging (e.g., ultrasound), estimating the risk of malignancy based on specific criteria.

Guides Treatment and Surveillance: It aids clinicians in determining whether further intervention (like biopsy or surgery) is necessary or if the lesions can be safely monitored, ensuring tailored and effective management for patients with ovarian or adnexal abnormalities.

BCLC Staging System: The Barcelona Clinic Liver Cancer (BCLC) system is a standard tool used to assess the stage of hepatocellular carcinoma (HCC) based on factors such as tumor size, number of lesions, liver function, and the patient’s general health status..

Personalized Treatment Guidance: BCLC provides a framework to guide treatment decisions for HCC, ensuring that interventions (like surgery, liver transplantation, or palliative care) are tailored to the cancer stage, liver function, and overall patient condition.